FDA Approves Investigational New Drug Application for Ceramide NanoLiposome

Article

The FDA has approved the investigational new drug application from Keystone Nano for Ceramide NanoLiposome to assess the product as a form of treatment for solid tumors.

The FDA has approved the investigational new drug application from Keystone Nano for Ceramide NanoLiposome to assess the product as a form of treatment for solid tumors. It will be tested in a phase 1 trial at the University of Maryland, University of Virginia, and the Medical University of South Carolina.

Through testing, the goal is to determine a safe dose level, as well as the efficacy of the drug as a treatment for cancer. In the past, ceramide has shown efficacy when used for liver, pancreatic, and breast cancer, as well as leukemia. Research tests indicate that Ceramide NanoLiposome can kill cancer cells without negatively impacting normal cells.

"The anti-cancer activity of ceramide has long been known in the laboratory," Dr. Mylisa Parette, Keystone Nano's Vice President of Research, said in a press release. "The proprietary formulation we are evaluating uses ceramide integrated into the membrane of a nanoliposome to overcome these barriers and allow us to exploit the novel properties of ceramide as an anti-cancer therapy."

In the phase 1 portion of the upcoming trial, patients with solid tumors will be recruited to determine dosing and safety for Ceramide NanoLiposome. A phase 2 portion will focus on liver cancer.

"This approval represents the conclusion of 1 phase of developing Ceramide, a truly novel anti-cancer agent, and the beginning of the very important human testing phase," Jeff Davidson, Keystone Nano's CEO, said in a press release. "This is a significant step forward in the development of Ceramide NanoLiposome for the treatment of cancer."

Related Videos
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.